|
Maprotiline Hydrochloride Tablets
» Maprotiline Hydrochloride Tablets contain not less than 90.0 percent and not more than 110.0 percent of the labeled amount of maprotiline hydrochloride (C20H23N·HCl).
Packaging and storage
Preserve in well-closed containers.
Identification
A:
Standard solutionDissolve 20 mg of USP Maprotiline Hydrochloride RS in 1.0 mL of methanol.
Test solution
Transfer a portion of powdered Tablets, equivalent to about 100 mg of maprotiline hydrochloride, to a glass-stoppered centrifuge tube. Add 5.0 mL of methanol to the tube, sonicate for 10 minutes, shake by mechanical means for 10 minutes, and centrifuge.
Procedure
In a suitable chromatographic chamber (see Chromatography
B:
The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that of the Standard preparation, as obtained in the Assay.
Dissolution
Medium:
dilute hydrochloric acid (7 in 1000); 900 mL.
Apparatus 2:
50 rpm.
Time:
60 minutes.
Procedure
Determine the amount of C20H23N·HCl dissolved from UV absorbances, using the difference between the absorbance maximum at about 272 nm and the absorbance minimum at about 268 nm, of filtered portions of the solution under test, suitably diluted with dilute hydrochloric acid (7 in 1000), in comparison with a Standard solution having a known concentration of USP Maprotiline Hydrochloride RS in the same Medium.
Tolerances
Not less than 75% (Q) of the labeled amount of C20H23N·HCl is dissolved in 60 minutes.
Uniformity of dosage units
Assay
Mobile phase
Dissolve 4 g of tetramethylammonium chloride in 495 mL of water, add 500 mL of acetonitrile and 1 mL of phosphoric acid, mix, filter, and degas. Make adjustments if necessary (see System Suitability under Chromatography
Standard preparation
Transfer an accurately weighed quantity of USP Maprotiline Hydrochloride RS to a suitable volumetric flask, and prepare a solution having a known concentration of about 0.75 mg per mL in a mixture of water, methanol, and 0.1 N hydrochloric acid (80:10:10) by sonicating the Reference Standard in the methanol and 0.1 N hydrochloric acid for 5 minutes to dissolve, diluting with water to volume, and mixing.
Assay preparation
Transfer not fewer than 15 Tablets to a 500-mL volumetric flask, add 100 mL of 0.1 N hydrochloric acid, sonicate, and shake occasionally for 5 minutes to disintegrate the Tablets. Add 100 mL of methanol, shake, and sonicate for 5 minutes. Dilute with water to volume, mix, and centrifuge. Dilute a portion of the supernatant quantitatively, and stepwise if necessary, with water to obtain a solution having a concentration of about 0.75 mg per mL. [noteFiltration through commonly available filters may result in unsatisfactory drug adsorption. ]
Chromatographic system
(see Chromatography
Procedure
Separately inject equal volumes (about 20 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the areas for the major peaks. Calculate the quantity, in mg, of C20H23N·HCl in the portion of Tablets taken by the formula:
(L / D)C(rU / rS)
in which L is the labeled amount, in mg, of maprotilene hydrochloride in each Tablet; D is the concentration, in mg per mL, of maprotilene hydrochloride in the Assay preparation, based on the labeled quantity per Tablet and the extent of dilution; C is the concentration, in mg per mL, of USP Maprotiline Hydrochloride RS in the Standard preparation; and rU and rS are the maprotilene peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 3767
|